UltraSight and EchoNous have collaborated to bring the benefits of cardiac imaging to healthcare professionals in multiple care settings.
Under the partnership, UltraSight’s real-time AI guidance software will be integrated with EchoNous’ Kosmos handheld ultrasound device.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
This enables capturing diagnostic quality cardiac images at the point of care and images can be read remotely.
UltraSight CEO Davidi Vortman said: “We know that image quality is the key to achieving an accurate patient diagnosis.
“This is why we are thrilled to collaborate with EchoNous, which provides superior image quality and offers one of the most advanced handheld ultrasound systems available on the market.”
Currently under FDA 510(k) review, UltraSight’s software was evaluated in a pivotal study which demonstrated that novice users have captured quality cardiac ultrasound images.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe software also received CE marking in the EU and UKCA marking in the UK.
It will act as a complementary AI guidance to the Kosmos ultrasound system as it has its own proprietary system with enhanced AI, enabling it to provide better image quality compared to cart-based systems and at less cost.
EchoNous CEO Graham Cox said: “UltraSight’s AI solution in conjunction with our own AI technology will help widespread use and adoption to provide Echocardiology exams in any location or setting.
“With this partnership, we will work toward offering remote clinicians the tools they need to make lifesaving diagnoses, cardiac monitoring and potentially improve cardiac care for patients in rural areas.”
